Global Needle Free Injection System Market Size, Share, Forecast Report 2024
The global needle free-injectors market size was exhibited at USD 1.50 billion in 2023 and is projected to hit around USD 3.21 billion by 2033, growing at a CAGR of 7.9% during the forecast period of 2024–2033.
Key Takeaways:
Needle-free Injectors Market Report Scope
| Report Coverage | Details |
| Market Size in 2024 | USD 1.50 Billion |
| Market Size by 2033 | USD 3.21 Billion |
| Growth Rate From 2024 to 2033 | CAGR of 7.9% |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Segments Covered | Product, Technology, Usability, Type, Application, Delivery Site, End-use, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Scope | North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
| Key Companies Profiled | PharmaJet; Crossject; Portal Instruments; NuGen Medical Devices; Inovio Pharmaceuticals; Antares Pharma, Inc; Aijex Pharma International Inc.; Ferring B.V.; Penjet Corporation; Medical International Technology Inc. |
Increasing number of regulatory approvals, rising preference for self-administration of drugs are expected to foster market growth. Needle-free devices provide pain less delivery and negate the risk of infection. Hence, the demand for these injectors is projected to rise during the forecast period.
The COVID-19 pandemic has positive impact on needle-free injectors market. The requirement and demand for mass vaccination needs and self-injectable devices have increased since the initiation of COVID-19. As COVID-19 cases have increased in all regions, the majority of the needle free-injectors market players have participated in R&D activities and started entering into agreements and partnerships with other industry firms and government organizations to develop and improve needle free-injectors.
Needle-free injectors provide higher safety for patients and healthcare workers by eliminating risks related to conventional infusion and injection technology such as drug preparation, needle insertion, and covering & disposing of needles. In addition, American Nurses Association stated that around 74.0% of accidental needlestick injuries are due to contamination and are likely to lead to infection. Treatments for these injuries is expensive. According to the CDC, treatment cost ranges from USD 500 to USD 3,000 or more per injury. These costs get multiplied during infection. The CDC has also projected that the number of needle stick injuries reported each year in hospitals in the U.S. is 385,000. On the other hand, European Agency of Safety and Health at Work stated that about 1.0 million needlestick injuries occur every year across the world.
Rising healthcare costs is the biggest concern faced by developing and developed economies. These regions are struggling to address cost-effective and quality care. Despite supportive health funding and insurance program, there has been a constant rise in healthcare cost in the U.S., which is influencing healthcare providers. Healthcare expenditure in the U.S. is around 2.4 times higher than the global average and is anticipated to increase by 68.0% in the coming ten years. With the help of needle-free injectors, patients can self-administer the drug subcutaneously at home, this is anticipated to reduce the number of visits to hospitals or other healthcare settings, thereby helping patients to limit their healthcare expenses.
Segments Insights:
Product Insights
The fillable segment held the largest revenue share in 2023 owing to their high adoption rates and wide availability throughout the globe. The prefilled segment held a considerable market share in 2023. Increasing application of prefilled needle-free injectors in insulin, vaccination, and other drug delivery is projected to augment the market growth. Surging preference for prefilled needle-free injectors by several healthcare professionals may strengthen the market growth.
Usability Insights
The reusable segment dominated the needle-free injectors market and accounted for a significant revenue share in 2021. Reusable needle free-injectors are mostly suggested by healthcare specialists as well as doctors to reduce the risk of infections and other harmful ailments. Reusable injectors provide excessive durability as they are manufactured from superior and precision-engineered materials, which also help doctors to reuse them several times.
The disposable segment accounted for the largest revenue share in 2023. Disposable needle free-injectors are easy to use for numerous, low-volume injections or variable dosing. Increasing awareness regarding benefits provided by drug delivery devices and surging concerns over the hazards related to needle stick injuries may enhance the segment growth.
Technology Insights
The gas powered needle-free injectors segment held the largest revenue share in 2023. Gas powered needle-free injectors are suitable for transdermal, subcutaneous, or intramuscular use. Increasing benefits associated with this technology, including improved dosage accuracy, rapid drug administration, faster response rate, and better diffusion into the tissue are predicted to augment the market demand.
Laser-powered needle-free injectors segment held a considerable market share in 2021. Recent advancements and innovations in laser powered needle-free injectors are anticipated to propel market growth.
Type Insights
The segmental growth is attributed to the increasing ability of a liquid jet to penetrate the skin and underlying fat layer without harming the integrity of the drug molecule or harming the skin. Hence surging demand for liquid-based needle-free injectors is anticipated to foster market growth. The powder-based needle free injectors segment held a significant CAGR during the forecast period. Several market players across the globe are focusing on developing powder-based needle-free injectors to strengthen their product portfolio.
Delivery Site Insights
The subcutaneous segment held the largest market share in 2023. The segmental growth is attributed to the greater effect as the drug moves to the capillaries and is carried to the bloodstream. The intradermal segment accounted for a significant CAGR during the progression period. Increasing preference for intradermal administration by several patients across the globe is anticipated to fuel market growth.
Application Insights
Vaccine delivery is among the leading application segment in needle-free injectors market. Increasing preference for vaccine administration is predicted to surge the demand for needle free-injectors during the forecast period. The pain management segment is expected to witness a significant CAGR during the forecast period. Increasing cases of medical conditions such as pain disorders, arthritis, and migraine is predicted to secure the market position.
End-use Insights
The hospitals segment captured the largest revenue share of in 2023. Hospitals require needle-free injectors in large quantities at nurse’s stations, operation theaters, emergency rooms, outpatient departments, and ambulatory services. Hospitals generally issue an open tender for the procurement of such devices. Growing hospitalization of patients coupled with a surge in the number of hospitals across the world is expected to contribute to market growth during the forecast period.
The homecare settings segment gained momentous growth in 2023. Advanced features of needle-free injectors are improving patient adherence toward drug delivery devices, and this is expected to aid in the growth of the home care segment.
Regional Insights
North America is anticipated to dominate the market at 43.0% in 2023 and is expected to grow over the forecast period owing to the presence of major market players in the U.S. coupled with the increasing prevalence of chronic and lifestyle-associated diseases. In addition, the growing trend was found throughout the U.S. and among Canadian citizens towards self-administration of medications. Hence the above-mentioned factors are anticipated to boost regional growth.
Europe accounted for the second-highest revenue share and is expected to witness a substantial CAGR during the forecast period. Advancements in medical technologies, rising adoption of needle-free injectors, and increasing healthcare spending are expected to contribute to the market growth during the forecast period.
Asia Pacific is expected to register the fastest CAGR around 8.16% over the forecast period, which can be attributed to favorable government initiatives for use of medical devices, increasing geriatric population base, and increasing healthcare expenditure in this region. Increase in aging population in several Asian countries, which is highly prone to chronic diseases, is expected to fuel the demand for needle-free injectors.
Some of the prominent players in the needle free-injectors market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the global needle free-injectors market.
Product
Technology
Usability
Type
Application
Delivery Site
End-use
By Region
Chapter 1 Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Type
1.1.3. Technology
1.1.4. Delivery Site
1.1.5. Usability
1.1.6. Application
1.1.7. End-use
1.1.8. Regional scope
1.1.9. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1.1. Commodity flow analysis (Model 1)
1.6.1.2. Approach 1: Commodity flow approach
1.6.1.3. Volume price analysis (Model 2)
1.6.1.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2 Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Type outlook
2.2.3. Technology outlook
2.2.4. Delivery site outlook
2.2.5. Usability outlook
2.2.6. Application outlook
2.2.7. End-use outlook
2.2.8. Regional outlook
2.3. Competitive Insights
Chapter 3 Needle-free Injectors Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of chronic disorders
3.4.1.2. Technological advancements
3.4.1.3. Increasing cases of needle-stick injures
3.4.2. Market restraint analysis
3.4.2.1. Lack of awareness in developing and underdeveloped economies
3.4.2.2. Stringent regulations
3.5. Needle-free Injectors Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier product
3.5.1.2. Buyer product
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4 Needle-free Injectors: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Fillable
4.1.2. Prefilled
4.2. Product Market Share, 2024 & 2033
4.3. Segment Dashboard
4.4. Global Needle-free Injectors Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5.1. Fillable
4.5.1.1. Market estimates and forecast 2021 to 2033
4.5.2. Prefilled
4.5.2.1. Market estimates and forecast 2021 to 2033
Chapter 5 Needle-free Injectors: Usability Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Disposable
5.1.2. Reusable
5.2. Usability Market Share, 2024 & 2033
5.3. Segment Dashboard
5.4. Global Needle-free Injectors Market by Usability Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5.1. Disposable
5.5.1.1. Market estimates and forecast 2021 to 2033
5.5.2. Reusable
5.5.2.1. Market estimates and forecast 2021 to 2033
Chapter 6 Needle-free Injectors: Application Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Vaccine Delivery
6.1.2. Insulin Delivery
6.1.3. Pain Management
6.1.4. Others
6.2. Application Market Share, 2024 & 2033
6.3. Segment Dashboard
6.4. Global Needle-free Injectors Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.5.1. Vaccine delivery
6.5.1.1. Market estimates and forecast 2021 to 2033
6.5.2. Insulin delivery
6.5.2.1. Market estimates and forecast 2021 to 2033
6.5.3. Pain management
6.5.3.1. Market estimates and forecast 2021 to 2033
6.5.4. Others
6.5.4.1. Market estimates and forecast 2021 to 2033
Chapter 7 Needle-free Injectors: Technology Estimates & Trend Analysis
7.1. Definitions and Scope
7.1.1. Spring-based needle-free injectors
7.1.2. Gas-powered needle-free injectors
7.1.3. Laser-powered needle-free injectors
7.1.4. Vibration-based needle-free injectors
7.2. Technology Market Share, 2024 & 2033
7.3. Segment Dashboard
7.4. Global Needle-free Injectors Market by Technology Outlook
7.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
7.5.1. Spring-based needle-free injectors
7.5.1.1. Market estimates and forecast 2021 to 2033
7.5.2. Gas-powered needle-free injectors
7.5.2.1. Market estimates and forecast 2021 to 2033
7.5.3. Laser-powered needle-free injectors
7.5.3.1. Market estimates and forecast 2021 to 2033
7.5.4. Vibration-based needle-free injectors
7.5.4.1. Market estimates and forecast 2021 to 2033
Chapter 8 Needle-free Injectors: Type Estimates & Trend Analysis
8.1. Definitions and Scope
8.1.1. Powder-based needle free injectors
8.1.2. Liquid-based needle free injectors
8.1.3. Projectile/depot-based needle free injectors
8.2. Type Market Share, 2024 & 2033
8.3. Segment Dashboard
8.4. Global Needle-free Injectors Market by Type Outlook
8.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
8.5.1. Powder-based needle free injectors
8.5.1.1. Market estimates and forecast 2021 to 2033
8.5.2. Liquid-based needle free injectors
8.5.2.1. Market estimates and forecast 2021 to 2033
8.5.3. Projectile/depot-based needle free injectors
8.5.3.1. Market estimates and forecast 2021 to 2033
Chapter 9 Needle-free Injectors: Delivery Site Estimates & Trend Analysis
9.1. Definitions and Scope
9.1.1. Subcutaneous
9.1.2. Intramuscular
9.1.3. Intradermal
9.2. Delivery Site Market Share, 2024 & 2033
9.3. Segment Dashboard
9.4. Global Needle-free Injectors Market by Delivery Site Outlook
9.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
9.5.1. Subcutaneous
9.5.1.1. Market estimates and forecast 2021 to 2033
9.5.2. Intramuscular
9.5.2.1. Market estimates and forecast 2021 to 2033
9.5.3. Intradermal
9.5.3.1. Market estimates and forecast 2021 to 2033
Chapter 10 Needle-free Injectors: End-use Estimates & Trend Analysis
10.1. Definitions and Scope
10.1.1. Hospitals & Clinics
10.1.2. Home Care Settings
10.1.3. Research Laboratories
10.2. End-use Market Share, 2024 & 2033
10.3. Segment Dashboard
10.4. Global Needle-free Injectors Market by End-use Outlook
10.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
10.5.1. Hospitals & clinics
10.5.1.1. Market estimates and forecast 2021 to 2033
10.5.2. Home care settings
10.5.2.1. Market estimates and forecast 2021 to 2033
10.5.3. Research laboratories
10.5.3.1. Market estimates and forecast 2021 to 2033
Chapter 11 Needle-free Injectors Market: Regional Estimates & Trend Analysis
11.1. Regional market share analysis, 2024 & 2033
11.2. Regional Market Dashboard
11.3. Global Regional Market Snapshot
11.4. Regional Market Share and Leading Players, 2022
11.4.1. North America
11.4.2. Europe
11.4.3. Asia Pacific
11.4.4. Latin America
11.4.5. Middle East and Africa
11.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
11.5.1. North America
11.5.2. Europe
11.5.3. Asia Pacific
11.5.4. Latin America
11.5.5. Middle East and Africa
11.6. Market Size, & Forecasts, Volume and Trend Analysis, 2021 to 2033:
11.7. North America
11.7.1. Market estimates and forecast, 2021-2033
11.7.2. U.S.
11.7.2.1. Market estimates and forecast, 2021-2033
11.7.3. Canada
11.7.3.1. Market estimates and forecast, 2021-2033
11.8. Europe
11.8.1. U.K.
11.8.1.1. Market estimates and forecast, 2021-2033
11.8.2. Germany
11.8.2.1. Market estimates and forecast, 2021-2033
11.8.3. France
11.8.3.1. Market estimates and forecast, 2021-2033
11.8.4. Italy
11.8.4.1. Market estimates and forecast, 2021-2033
11.8.5. Spain
11.8.5.1. Market estimates and forecast, 2021-2033
11.9. Asia Pacific
11.9.1. China
11.9.1.1. Market estimates and forecast, 2021-2033
11.9.2. Japan
11.9.2.1. Market estimates and forecast, 2021-2033
11.9.3. India
11.9.3.1. Market estimates and forecast, 2021-2033
11.9.4. South Korea
11.9.4.1. Market estimates and forecast, 2021-2033
11.9.5. Australia
11.9.5.1. Market estimates and forecast, 2021-2033
11.10. Latin America
11.10.1. Brazil
11.10.1.1. Market estimates and forecast, 2021-2033
11.10.2. Mexico
11.10.2.1. Market estimates and forecast, 2021-2033
11.10.3. Argentina
11.10.3.1. Market estimates and forecast, 2021-2033
11.10.4. Colombia
11.10.4.1. Market estimates and forecast, 2021-2033
11.11. MEA
11.11.1. Saudi Arabia
11.11.1.1. Market estimates and forecast, 2021-2033
11.11.2. South Africa
11.11.2.1. Market estimates and forecast, 2021-2033
11.11.3. UAE
11.11.3.1. Market estimates and forecast, 2021-2033
Chapter 12 Competitive Landscape
12.1. Recent Developments & Impact Analysis, By Key Market Participants
12.2. Company/Competition Categorization
12.2.1. Innovators
12.3. Vendor Landscape
12.3.1. List of key distributors and channel partners
12.3.2. Key customers
12.3.3. Key company market share analysis, 2022
12.3.4. PharmaJet.
12.3.4.1. Company overview
12.3.4.2. Financial performance
12.3.4.3. Product benchmarking
12.3.4.4. Strategic initiatives
12.3.5. Crossject
12.3.5.1. Company overview
12.3.5.2. Financial performance
12.3.5.3. Product benchmarking
12.3.5.4. Strategic initiatives
12.3.6. Portal Instruments
12.3.6.1. Company overview
12.3.6.2. Financial performance
12.3.6.3. Product benchmarking
12.3.6.4. Strategic initiatives
12.3.7. NuGen Medical Devices
12.3.7.1. Company overview
12.3.7.2. Financial performance
12.3.7.3. Product benchmarking
12.3.7.4. Strategic initiatives
12.3.8. Inovio Pharmaceuticals
12.3.8.1. Company overview
12.3.8.2. Financial performance
12.3.8.3. Product benchmarking
12.3.8.4. Strategic initiatives
12.3.9. Antares Pharma, Inc
12.3.9.1. Company overview
12.3.9.2. Financial performance
12.3.9.3. Product benchmarking
12.3.9.4. Strategic initiatives
12.3.10. Aijex Pharma International Inc.
12.3.10.1. Company overview
12.3.10.2. Financial performance
12.3.10.3. Product benchmarking
12.3.10.4. Strategic initiatives
12.3.11. Ferring B.V.
12.3.11.1. Company overview
12.3.11.2. Financial performance
12.3.11.3. Product benchmarking
12.3.11.4. Strategic initiatives
12.3.12. Penjet Corporation
12.3.12.1. Company overview
12.3.12.2. Financial performance
12.3.12.3. Product benchmarking
12.3.12.4. Strategic initiatives
12.3.13. Medical International Technology Inc.
12.3.13.1. Company overview
12.3.13.2. Financial performance
12.3.13.3. Product benchmarking
12.3.13.4. Strategic initiatives
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers